ENTOURAGE HEALTH CORP. Entourage Health Corp. announced it has entered into an amended supply agreement (the ?Supply Agreement?) with HEXO Corp. (?HEXO?).
The amendments, amongst other things, extend the initial term of the agreement, securing Entourage's ongoing access to high-quality bulk cannabis biomass for its product portfolio. The prices of all products supplied under the Supply Agreement are fixed but subject to limited and periodical adjustments depending on prevailing production costs. The amended terms follow HEXO?s acquisition by Tilray Brands Inc. (?Tilray?), prompting Entourage to shift its sourcing strategy, now obtaining bulk cannabis from Tilray cultivation sites as needed.
Simultaneously, the obligations of HEXO under the Supply Agreement have been assigned to Aphria Inc., Tilray's principal operating entity and license holder. Throughout this transition, Entourage has remained proactive, fostering continuous collaboration with Tilray to address all amendments. This effort represents a commitment to not only secure a consistent, high-quality cannabis supply but also to explore further opportunities.
